Thus pharmacological inhibition of mTOR might inhibit the quasi-programmed endochondral ossification that, as argued here, is the main pathogenetic process in OA in humans; in clinical trials, mTOR inhibitors have been shown to inhibit rheumatoid arthritis (Lin et al., 2022). Here, MTOR is linked to rheumatoid arthritis.